ICCC - IMMUCELL CORP /DE/

6.52
-0.010   -0.153%

Share volume: 9,481
Last Updated: 03-27-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$6.53
-0.01
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-14-2024 08-13-2024 11-13-2024 03-28-2025 05-14-2025 08-14-2025 11-13-2025
Total revenue 7.258 M 5.473 M 6.012 M 7.751 M 8.067 M 6.445 M 5.506 M
Cost of revenue 4.962 M 4.242 M 4.428 M 4.919 M 4.713 M 3.627 M 3.143 M
Gross profit 2.295 M 1.230 M 1.584 M 2.832 M 3.354 M 2.818 M 2.363 M
    -46.39% 28.69% 78.82% 18.45% -15.98% -16.14%  
Operating expenses 1.794 M 1.632 M 1.314 M 1.374 M 1.380 M 1.552 M 1.424 M
Selling general and admin 531.938 K 601.634 K 528.267 K 554.710 K 622.843 K 720.418 K 729.421 K
Research and development 1.263 M 1.031 M 786.136 K 819.394 K 756.847 K 831.858 K 694.311 K
Total expenses 2.595 M 2.617 M 2.158 M 2.210 M 2.236 M 2.248 M 2.343 M
    0.84% -17.52% 2.40% 1.18% 0.54% 4.21%  
Operating income -300.052 K -1.387 M -574.894 K 621.394 K 1.118 M 569.562 K 20.075 K
Ebit -436.528 K -1.530 M -700.350 K 520.591 K 1.449 M 503.784 K -135.292 K
Pretax income -436.528 K -1.530 M -700.350 K 520.591 K 1.449 M 503.784 K -135.292 K
    250.56% -54.23% -174.33% 178.32% -65.23% -126.86%  
Income tax 1.340 K 1.340 K 1.340 K 6.036 K 1.904 K 1.904 K 4.456 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -437.868 K -1.532 M -701.690 K 514.555 K 1.447 M 501.880 K -139.748 K
    -249.79% 54.19% 173.33% 181.21% -65.32% -127.84%